Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study

Abstract In recent years, the incidence of malignancies among young people, including early-onset esophageal cancer (EOEC), has been increasing globally. This study aims to compare the survival outcomes of metastatic EOEC and late-onset esophageal cancer (LOEC) and to identify prognostic factors. Pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinwei Guo, Lang Qin, Rui Yang, Yangchen Liu, Shaobing Zhou, Weiwei Zhao
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-08618-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399754744659968
author Xinwei Guo
Lang Qin
Rui Yang
Yangchen Liu
Shaobing Zhou
Weiwei Zhao
author_facet Xinwei Guo
Lang Qin
Rui Yang
Yangchen Liu
Shaobing Zhou
Weiwei Zhao
author_sort Xinwei Guo
collection DOAJ
description Abstract In recent years, the incidence of malignancies among young people, including early-onset esophageal cancer (EOEC), has been increasing globally. This study aims to compare the survival outcomes of metastatic EOEC and late-onset esophageal cancer (LOEC) and to identify prognostic factors. Patient data were collected from the Surveillance, Epidemiology, and End Results database. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using univariate and multivariate Cox regression models. Propensity score matching (PSM) was applied to balance baseline differences. The Kaplan–Meier method and log-rank test were used to compare overall survival (OS). A total of 11,738 cases of metastatic esophageal cancer were included from 2010 to 2020, with 996 EOEC patients and 10,742 LOEC patients. The mean OS for EOEC patients was 14.30 months (95% CI 12.53–16.06 months), compared to 10.89 months (95% CI 10.45–11.33 months) for LOEC patients. Multivariate Cox regression analysis revealed that marital status, histological type, tumor grade, bone metastasis, liver metastasis, surgery, and chemotherapy were independent prognostic factors for EOEC patients (p < 0.05). After adjusting for variables other than age using PSM, the results still indicated better OS for EOEC patients (p = 0.031). Further subgroup analysis showed that chemotherapy primarily influenced survival outcomes in both groups (p = 0.012). Metastatic EOEC showed better OS outcomes compared to LOEC, and EOEC patients benefited more from chemotherapy than LOEC patients.
format Article
id doaj-art-3a65aba37e4e49cdabe9b6791668325c
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-3a65aba37e4e49cdabe9b6791668325c2025-08-20T03:38:15ZengNature PortfolioScientific Reports2045-23222025-07-0115111210.1038/s41598-025-08618-7Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based studyXinwei Guo0Lang Qin1Rui Yang2Yangchen Liu3Shaobing Zhou4Weiwei Zhao5Department of Radiotherapy, Taixing People’s Hospital Affiliated to Yangzhou UniversityDepartment of Radiotherapy, Huainan Chaoyang HospitalDepartment of Radiotherapy, Taixing People’s Hospital Affiliated to Yangzhou UniversityDepartment of Radiotherapy, Taixing People’s Hospital Affiliated to Yangzhou UniversityDepartment of Radiotherapy, Taixing People’s Hospital Affiliated to Yangzhou UniversityDepartment of Radiotherapy, Taixing People’s Hospital Affiliated to Yangzhou UniversityAbstract In recent years, the incidence of malignancies among young people, including early-onset esophageal cancer (EOEC), has been increasing globally. This study aims to compare the survival outcomes of metastatic EOEC and late-onset esophageal cancer (LOEC) and to identify prognostic factors. Patient data were collected from the Surveillance, Epidemiology, and End Results database. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using univariate and multivariate Cox regression models. Propensity score matching (PSM) was applied to balance baseline differences. The Kaplan–Meier method and log-rank test were used to compare overall survival (OS). A total of 11,738 cases of metastatic esophageal cancer were included from 2010 to 2020, with 996 EOEC patients and 10,742 LOEC patients. The mean OS for EOEC patients was 14.30 months (95% CI 12.53–16.06 months), compared to 10.89 months (95% CI 10.45–11.33 months) for LOEC patients. Multivariate Cox regression analysis revealed that marital status, histological type, tumor grade, bone metastasis, liver metastasis, surgery, and chemotherapy were independent prognostic factors for EOEC patients (p < 0.05). After adjusting for variables other than age using PSM, the results still indicated better OS for EOEC patients (p = 0.031). Further subgroup analysis showed that chemotherapy primarily influenced survival outcomes in both groups (p = 0.012). Metastatic EOEC showed better OS outcomes compared to LOEC, and EOEC patients benefited more from chemotherapy than LOEC patients.https://doi.org/10.1038/s41598-025-08618-7Esophageal cancerEarly-onsetPrognosisMetastaticSEER
spellingShingle Xinwei Guo
Lang Qin
Rui Yang
Yangchen Liu
Shaobing Zhou
Weiwei Zhao
Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study
Scientific Reports
Esophageal cancer
Early-onset
Prognosis
Metastatic
SEER
title Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study
title_full Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study
title_fullStr Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study
title_full_unstemmed Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study
title_short Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: a population-based study
title_sort survival outcomes and prognostic factors of early onset and late onset metastatic esophageal cancer a population based study
topic Esophageal cancer
Early-onset
Prognosis
Metastatic
SEER
url https://doi.org/10.1038/s41598-025-08618-7
work_keys_str_mv AT xinweiguo survivaloutcomesandprognosticfactorsofearlyonsetandlateonsetmetastaticesophagealcancerapopulationbasedstudy
AT langqin survivaloutcomesandprognosticfactorsofearlyonsetandlateonsetmetastaticesophagealcancerapopulationbasedstudy
AT ruiyang survivaloutcomesandprognosticfactorsofearlyonsetandlateonsetmetastaticesophagealcancerapopulationbasedstudy
AT yangchenliu survivaloutcomesandprognosticfactorsofearlyonsetandlateonsetmetastaticesophagealcancerapopulationbasedstudy
AT shaobingzhou survivaloutcomesandprognosticfactorsofearlyonsetandlateonsetmetastaticesophagealcancerapopulationbasedstudy
AT weiweizhao survivaloutcomesandprognosticfactorsofearlyonsetandlateonsetmetastaticesophagealcancerapopulationbasedstudy